Memorial Sloan Kettering Cancer Center on LinkedIn: Researchers at Memorial Sloan Kettering Cancer Center (MSK) are making… (2024)

We’re looking forward to hearing from the incredible physicians and scientists from MSK who are presenting at the 2024 American Society of Clinical Oncology (ASCO) Annual Meeting on May 31-June 4 in Chicago. Here’s a preview of some of the top speakers: https://bit.ly/4bPwqWb #ASCO24

235

3 Comments

Memorial Sloan Kettering Cancer Center (MSK) has been recognized as an LGBTQ+ Healthcare Equality Leader, receiving a maximum overall score of 100 from the Human Rights Campaign on its 2024 Healthcare Equity Index (HEI).“We’re proud to receive this continued recognition, which reflects the pride we all share in working at MSK,” says Beau Amaya, Director of Patient and Caregiver Education at MSK and co-leader of MSK’s LGBTQ+ Pride ERN. “Our staff celebrates diversity, and our leaders exemplify inclusion and health equity. This honor motivates us to keep driving change and making significant progress for the LGBTQ+ community.”Learn more about how MSK is fostering an inclusive and equitable environment for LGBTQ+ individuals: https://bit.ly/3yMLcPn

52

Meet Steve Dotson, Derick Barnett, and Kenya Webster, three Radiology Aides at MSK that transitioned into their positions from MSK's Environmental Services (EVS) team.“We first met Steve when he was assigned as our midday EVS staff member,” says Tom Mair, Manager of Diagnostic Radiology at MSK. “Steve was such a kind EVS team member who always took an interest in the patients’ needs."When the opportunity came up for a role in Radiology, Tom encouraged Steve to apply. Derick, along with another colleague, Kenya, were recommended by Steve. By December 2023, they all successfully transitioned from EVS to the Radiology team.Steve, Derick and Kenya have all discovered how multifaceted patient care can be and have fully embraced their interactions with patients at MSK. “I am here for the patients because it is all about them,” Derick says. “I love what I do and taking care of these people the same way that I would want to be treated."

290

13 Comments

An innovative radiation treatment using a greatly reduced dose that is typically given to patients after surgical removal of human papillomavirus(HPV)-positive head and neck tumors may now help some of those patients avoid surgery altogether. The low-dose approach, pioneered by radiation oncologist Dr. Nancy Lee, reduces side effects from treatment that make eating and swallowing difficult. “This has been an absolute game-changer for treating certain people with throat cancers” caused by HPV, Dr. Lee says, and it can be extended to all other types of HPV-positive head and neck cancers. “The difference in toxicity is dramatic.” Learn more about Dr. Lee’s research that she presented at the American Society of Clinical Oncology (ASCO) Annual Meeting: https://bit.ly/45iJe5t #ASCO24

103

Dr. Robert Daly, a thoracic oncologist at Memorial Sloan Kettering (MSK), presented clinical trial research delivering high quality cancer care at home by integrating telemedicine into both immunotherapy treatment and integrative medicine at the American Society of Clinical Oncology (ASCO) Annual Meeting. “The next frontier is delivering safe and effective treatment at home, which can help patients and care givers by making care less stressful and reducing concerns like time and financial toxicities that limit people’s access to high quality care,” Dr. Daly says. Learn more about both of these research projects: https://bit.ly/3XbDAjw #ASCO24

147

4 Comments

Presentations by MSK researchers Drs. Bob Li, Helena Yu, and James Isbell at the American Society of Clinical Oncology (ASCO) Annual Meeting revealed encouraging clinical trial results and promise of a more sensitive “liquid biopsy,” all of which could improve lung cancer treatment. Learn more about their research: https://bit.ly/45cmKmB#ASCO24

81

Radiation oncologist & early drug development specialist Dr. Nancy Lee will present research on intra-treatment hypoxia directed major radiation de-escalation as definitive treatment for human papillomavirus (HPV)-related oropharyngeal cancer at the American Society of Clinical Oncology (ASCO) Annual Meeting. #ASCO24Learn more: https://bit.ly/3yWvWPR

57

Thoracic oncologist Dr. Robert Daly will present acute care and overall survival results of a randomized trial of a virtual health intervention during routine #cancer treatment today at the American Society of Clinical Oncology (ASCO) Annual Meeting. #ASCO24Learn more: https://bit.ly/3Vh1RCq

44

MSK researchers Dr. Sandra D'Angelo, Dr. William Tap, and Dr. Michael Offin presented promising studies on treating rare solid tumors, including mesothelioma and three types of soft-tissue tumors, at the American Society of Clinical Oncology (ASCO) Annual Meeting. The results of these clinical trials illustrate MSK’s depth and breadth of experience in managing all types of cancer, including those so rare that other doctors may see only a few cases in their whole careers. Learn more about the findings: https://bit.ly/4bGCi4z#ASCO24

122

1 Comment